Solid-liquid equilibrium and thermodynamic properties of dipyridamole form II in pure solvents and mixture of (N-methyl pyrrolidone plus isopropanol)

被引:53
作者
Li, Rongrong [1 ]
Fu, Liting [1 ]
Zhang, Jieyu [1 ]
Wang, Wei [1 ]
Chen, Xianlang [1 ]
Zhao, Jia [2 ]
Han, Deman [1 ]
机构
[1] Taizhou Univ, Sch Pharmaceut & Mat Engn, Taizhou 318000, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, Ind Catalysis Inst, Hangzhou 310014, Zhejiang, Peoples R China
关键词
Dipyridamole; Solubility profile; Solvent effect; Thermodynamic properties; SOLUBILITY; ETHANOL;
D O I
10.1016/j.jct.2019.105981
中图分类号
O414.1 [热力学];
学科分类号
摘要
The solid-liquid equilibria of a poorly soluble drug namely dipyridamole were assayed to determine solubility in pure and binary mixtures between 273.15 K and 313.15 K under atmospheric pressure. The solubility profiles of dipyridamole in pure and mixed solvents were evaluated by some thermodynamic models. The maximum solubility in mole fraction was obtained in pure N-methyl pyrrolidone (NMP) in all tested solvents. In mixtures of (NMP + isopropanol), the values increased monotonically with the increasing temperature and mass fraction of NMP. The Kamlet, Abboud and Taft Linear Solvation Energy Relationship (KAT-LSER) model was applied to analyze the effect of the solute-solvent intermolecular interactions on the solubility. The results of dissolution thermodynamic properties indicate that the dissolution behavior were endothermic and entropy-driven in all tested solvents. The experimental solubility data and mathematically correlated equations of dipyridamole estimated in this work may be useful for studies on the crystallization process of the final step of dipyridamole synthesis, for the purification dipyridamole of pharmaceutical applications. (C) 2019 Elsevier Ltd.
引用
收藏
页数:6
相关论文
共 26 条
[1]   Solubilities of o-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, and p-toluic acid, and magnesium-DL-aspartate in water from T = (278 to 348) K [J].
Apelblat, A ;
Manzurola, E .
JOURNAL OF CHEMICAL THERMODYNAMICS, 1999, 31 (01) :85-91
[2]   Antiplatelet therapy in cardiovascular disease [J].
Behan, MWH ;
Storey, RF .
POSTGRADUATE MEDICAL JOURNAL, 2004, 80 (941) :155-164
[3]   Thermoanalytical and spectroscopic characterization of solid state dipyridamole [J].
Berbenni, V ;
Marini, A ;
Bruni, G ;
Maggioni, A ;
Cogliati, P .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2002, 68 (02) :413-422
[4]   Dipyridamole, cerebrovascular disease, and the vasculature [J].
Chakrabarti, Subrata ;
Freedman, Jane E. .
VASCULAR PHARMACOLOGY, 2008, 48 (4-6) :143-149
[5]   Solubility Determination and Thermodynamic Modeling of Buprofezin in Different Solvents and Mixing Properties of Solutions [J].
Chen, Xiaoying ;
Zhou, Zehua ;
Chen, Jingjing ;
Chu, Chu ;
Zheng, Jianli ;
Wang, Shiting ;
Jia, Wenping ;
Zhao, Jia ;
Li, Rongrong ;
Han, Deman .
JOURNAL OF CHEMICAL AND ENGINEERING DATA, 2019, 64 (03) :1177-1186
[6]   Near-field amplification of antithrombotic effects of dipyridamole through vessel wall cells [J].
Eisert, WG .
NEUROLOGY, 2001, 57 (05) :S20-S23
[7]  
Fangwen S., 2018, Production Method of Dipyridamole Bulk Drug, Patent No. [CN108069972A, 108069972]
[8]  
Gore VG, 2011, WO Patent, Patent No. [2011,151,640, 2011151640]
[9]  
HARKER LA, 1983, THROMB RES, P39
[10]   Prediction of drug solubility in ethanol-ethyl acetate mixtures at various temperatures using the Jouyban-Acree model [J].
Jouybanl, A. ;
Acree, W. E., Jr. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2007, 17 (02) :159-160